Dr Catherine Bones-Saunders
People_

Dr Catherine Bones-Saunders

Clinical Senior Lecturer
Sydney Medical School
Westmead Clinical School
Faculty of Medicine and Health

Publications

Journals

  • Selvakumar, D., Brown, P., Geenty, P., Barnett, R., Saunders, C., Altman, M., Thomas, L. (2020). Comparative Assessments of Left and Right Ventricular Function by Two-Dimensional, Contrast Enhanced and Three-Dimensional Echocardiography with Gated Heart Pool Scans in Patients Following Myocardial Infarction. American Journal of Cardiology, 134, 14-23. [More Information]
  • Moujaber, T., Etemadmoghadam, D., Kennedy, C., Chiew, Y., Balleine, R., Saunders, C., Wain, G., Gao, B., Hogg, R., Srirangan, S., Harnett, P., deFazio, A., et al (2018). BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition. JCO Precision Oncology, 2, 1-14. [More Information]
  • Carlino, M., Saunders, C., Haydu, L., Menzies, A., Curtis, C., Lebowitz, P., Kefford, R., Long, G. (2013). 18F-labelled fluorodeoxyglucose-positron emission tomography (FDG-PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanoma. European Journal of Cancer, 49(2), 395-402. [More Information]

2020

  • Selvakumar, D., Brown, P., Geenty, P., Barnett, R., Saunders, C., Altman, M., Thomas, L. (2020). Comparative Assessments of Left and Right Ventricular Function by Two-Dimensional, Contrast Enhanced and Three-Dimensional Echocardiography with Gated Heart Pool Scans in Patients Following Myocardial Infarction. American Journal of Cardiology, 134, 14-23. [More Information]

2018

  • Moujaber, T., Etemadmoghadam, D., Kennedy, C., Chiew, Y., Balleine, R., Saunders, C., Wain, G., Gao, B., Hogg, R., Srirangan, S., Harnett, P., deFazio, A., et al (2018). BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition. JCO Precision Oncology, 2, 1-14. [More Information]

2013

  • Carlino, M., Saunders, C., Haydu, L., Menzies, A., Curtis, C., Lebowitz, P., Kefford, R., Long, G. (2013). 18F-labelled fluorodeoxyglucose-positron emission tomography (FDG-PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanoma. European Journal of Cancer, 49(2), 395-402. [More Information]
  • Carlino, M., Gowrishankar, K., Saunders, C., Pupo, G., Snoyman, S., Zhang, X., Saw, R., Becker, T., Kefford, R., Long, G., Rizos, H. (2013). Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition Following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma. Molecular Cancer Therapeutics, 12(7), 1332-1342. [More Information]